OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Biotechnology is 59. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Subscription and Copyright information	214
Advisory Board and Contents	184
Bridging the path to multiplexed molecular diagnostics	182
Electronic plants: the future of agriculture and urban ecosystems?	178
CRISPR-based technologies for large DNA insertions	170
SynMADE: synthetic microbiota across diverse ecosystems	167
Engineering biology approaches to modulate bacterial biofilms	146
Unlocking the potential of stem-cell-derived ‘synthetic’ embryo models	141
Healing wounds with plasma-activated hydrogel therapy	140
Auricular repair: symphony between scaffolds and stem cells	138
Microalgae: a revolution for salt-affected soil remediation	133
Smart materials: rational design in biosystems via artificial intelligence	120
Scalable tissue biofabrication via perfusable hollow fiber arrays for cultured meat applications	116
Phytohormones: novel strategy for removing emerging contaminants and recovering resources	112
Prime editing: advances and therapeutic applications	111
Cofactor engineering powers next-generation biomanufacturing	103
The green revolution of food waste upcycling to produce polyhydroxyalkanoates	99
Manipulating immune activity of macrophages: a materials and mechanics perspective	98
Vector-free intra-airway in vivo epigenetic editing	94
Analyzing and understanding the robustness of bioprocesses	92
Advisory Board and Contents	91
Subscription and Copyright information	89
Subscription and Copyright information	87
Subscription and Copyright information	85
Advisory Board and Contents	84

UFSC Biotech Network: a transdisciplinary platform for biotechnology innovation in Brazil	84
Subscription and Copyright information	83
A high-performance protein preparation approach in a single column-free step	83
Towards biomanufacturing of cultured meat	82
Extended human lymph node explants for evaluation of adaptive immunity	81
J. Craig Venter (1946—2026)	81
Beyond waste: understanding urine’s potential in precision medicine	80
Integrating bicarbonate-based microalgal production with alkaline sewage for ocean negative carbon emissions	80
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases	78
Influence of titer, rate, yield, and scale on the cost and life-cycle emissions of biomanufacturing	78
Efficient genome-editing tools to engineer the recalcitrant non-model industrial microorganism Zymomonas mobilis	77
Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation	76
Nanobotic microbiomes against emerging vascular pathogens in agriculture	76
Next-generation digital biomarkers: continuous molecular health monitoring using wearable devices	76
Emerging strategies to develop novel genetically encoded biosensors	75
Molecular design of microalgae as sustainable cell factories	75
Machine learning to predict de novo protein–protein interactions	75
The GPS for drug development: navigating with evidence from human populations	73
Engineering the mangrove soil microbiome for selection of polyethylene terephthalate-transforming bacterial consortia	72
Engineering single-dose plasmid DNA for sustained in vivo delivery of designer incretins	72
Biotechnologies based on the fungal bioluminescence pathway	71
Patentability of antibodies in the artificial intelligence era	71
Printhead on a chip: empowering droplet-based bioprinting with microfluidics	69
Can protein expression be ‘solved’?	68
Translational organoid technology – the convergence of chemical, mechanical, and computational biology	67
Machine learning in bioprocess development: from promise to practice	66
Manufacturing innovation to drive down cell therapy costs	66
Mini-bones: miniaturized bone in vitro models	66
Metabolic and immunomodulatory control of type 2 diabetes via generating cellular itaconate reservoirs by inflammatory-targeting gene-therapy nanovesicles	64
Advisory Board and Contents	64
Estimating environmental impacts of early-stage bioprocesses	63
Dynamically regulating metabolic fluxes with synthetic metabolons	62
Engineered bacterial therapeutics with material solutions	61
Improving awareness, understanding, and enforcement of responsibilities and regulations in Blue Biotechnology	61